MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Pulmonx Corporation DIO Ratio 2011-2026 | LUNG
Annual DIO Ratio Pulmonx Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 282 | 319 | 408 | 386 | 340 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 408 | 282 | 347 |
Quarterly DIO Ratio Pulmonx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 271 | 226 | 248 | - | 289 | 285 | 325 | - | 312 | 319 | 349 | - | 474 | 485 | 590 | - | 368 | 364 | 393 | - | 311 | 368 | 251 | - | 94.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 590 | 94.9 | 333 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
216 | $ 39.08 | -1.83 % | $ 5.82 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.79 | 3.73 % | $ 559 M |  Israel |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.49 | -0.38 % | $ 121 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.2 | $ 9.41 | -2.39 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
205 | $ 43.34 | -5.35 % | $ 1.35 B | USA |
 |
IRIDEX Corporation
IRIX
|
125 | $ 1.45 | 2.84 % | $ 23.4 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
251 | $ 104.65 | 0.88 % | $ 1.33 B | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
238 | $ 29.78 | -2.84 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
213 | $ 3.18 | -3.05 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
164 | $ 0.52 | -5.19 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | Israel |
 |
Medtronic PLC
MDT
|
168 | $ 96.73 | -1.38 % | $ 124 B | USA |
 |
Cytosorbents Corporation
CTSO
|
106 | $ 0.79 | 5.78 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
83.8 | $ 182.92 | -3.23 % | $ 13.7 B | USA |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
220 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
790 | $ 3.73 | -3.37 % | $ 790 M | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.96 | -3.54 % | $ 148 M |  France |
 |
Abbott Laboratories
ABT
|
120 | $ 113.53 | -0.49 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
355 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
291 | - | - | $ 217 M | USA |
 |
Orthofix Medical
OFIX
|
258 | $ 13.02 | -2.62 % | $ 516 M |  Curacao |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 73.88 | -3.07 % | $ 109 B | USA |
 |
PAVmed
PAVM
|
11.1 | $ 9.94 | -0.4 % | $ 71.9 M | USA |
 |
Penumbra
PEN
|
332 | $ 340.23 | -0.61 % | $ 13.2 B | USA |